CBD blocks THC's psychosis-like effects in the brain by reversing a specific molecular signaling pathway

What the researchers found

Intra-hippocampal THC increased VTA dopamine neuron firing and bursting, decreased GABA frequency, and amplified oscillatory activity via ERK1-2 phosphorylation. THC also potentiated emotional salience in behavioral tests. CBD co-administration reversed all changes by downregulating pERK1-2, and pharmacological reactivation of pERK1-2 blocked CBD's protective effects.

Why it matters

This identifies the first specific molecular mechanism by which CBD counteracts THC's psychosis-like effects: ERK1-2 phosphorylation in the hippocampus. This could explain why high-THC/low-CBD strains are associated with greater psychosis risk and inform both strain recommendations and drug development.

The numbers in context

THC increased VTA DA frequency and bursting, decreased GABA frequency, amplified beta/gamma/epsilon oscillations. All effects reversed by CBD co-administration. Mechanism: THC upregulates pERK1-2; CBD downregulates it. Pharmacological ERK reactivation blocked CBD's protective effect.

How the study worked

In vivo electrophysiology in male Sprague Dawley rats with intra-hippocampal drug delivery. Measured VTA dopamine and GABA neuron activity, oscillatory magnitudes, and pERK1-2 levels. Behavioral tests included morphine place preference and fear conditioning assays.

What this study cannot tell us

Rat model with direct hippocampal injection, not oral or inhaled cannabinoid administration. Acute effects only. Male rats only. The translation from this specific mechanism to human psychosis risk is assumed but not demonstrated.

How to read the evidence

Preliminary: rigorous mechanistic animal study with multiple converging measures, published in Journal of Neuroscience.

When this study was published

Published in 2019 in The Journal of Neuroscience.

The bigger picture

The epidemiological finding that high-THC/low-CBD cannabis increases psychosis risk now has a molecular explanation. ERK signaling in the hippocampus is the nexus where THC and CBD exert opposing effects on the dopamine system, providing a drug development target.

Questions still open

• Would CBD doses achievable through normal consumption be sufficient to block THC's ERK effects? Could ERK1-2 inhibitors serve as antipsychotics? Does this mechanism explain individual differences in THC sensitivity?

Common questions

Read the original research

Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.

The Journal of neuroscience : the official journal of the Society for Neuroscience, 39(44), 8762-8777

Citation

Hudson, Roger; Renard, Justine; Norris, Christopher; Rushlow, Walter J; Laviolette, Steven R. (2019). Cannabidiol Counteracts the Psychotropic Side-Effects of Δ-9-Tetrahydrocannabinol in the Ventral Hippocampus through Bidirectional Control of ERK1-2 Phosphorylation.. The Journal of neuroscience : the official journal of the Society for Neuroscience, 39(44), 8762-8777. https://doi.org/10.1523/JNEUROSCI.0708-19.2019

Explore the wider topic

• CBD Oil Quality Guide: How to Avoid Snake Oil
• Anxiety After Quitting Weed: When to Consider Medication
• Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
• Cannabis for Chronic Pain: What the Research Actually Supports
• Cannabis and Epilepsy: The Epidiolex Story and What It Means
• Does CBD Actually Work for Anxiety? What the Evidence Shows
• Does CBD Help with Weed Withdrawal? What Studies Show
• CBD vs THC: The Differences That Actually Matter
• The Proven Medical Benefits of Cannabis: What Research Supports
• Quitting Weed Before Surgery
• Weed and Medications: What Changes When You Quit
• Quitting Weed During Pregnancy: What You Need to Know
• Quitting Weed While Pregnant: What You Need to Know
• Cannabis and Older Adults: Risks Seniors Should Know
• Cannabis and Breastfeeding: THC in Breast Milk